Skip to main content
. 2019 Jun 14;68(8):1223–1233. doi: 10.1007/s00262-019-02355-3

Fig. 4.

Fig. 4

The prognostic values of intratumoral pDCs combined with IL-17+ cells (a), with Treg cells (b), and with Treg cells and IL-17+ cells (c) in HCC patients. The predictive ability for OS (d) and TTR (e) of pDCs, pDCs and IL-17+ cells, pDCs and Treg cells, and pDCs, IL-17+, and Treg cells compared with that of other clinical parameters by receiver operating characteristic curves for 224 HCC patients. The area under the curve with 95% confidence interval is shown